Gemcitabine (AN) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: obidoxime
Brand name
(ARTG)
: GEMCITABINE AN gemcitabine (as hydrochloride) 200 mg/20 mL concentrated injection vialWhat this medicine is used for
(ARTG)
Treatment of patients with locally advanced or metastatic non-small celll lung cancer. Treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Treatment of patients with 5-FU refractory pancreatic cancer. Treatment of patients with bladder cancer, alone or in combination with cisplatin. Treatment, in combinatin with paclitaxel, of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Treatment, in combinatin with carboplatin, of patients with recurrent epithelial ovarian carcinoma, who have relapsed > six months following platinum based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- Clear colourless solutin in a flint vial with a rubber stopper and aluminium seal
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 6 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
